SEC Filings for Adaptimmune Therapeutics plc (ADAP)

$ 9.79   -0.20 (-2.00%) Volume: 696.39k 4:00 PM EDT 2-Jul-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
4Statement of changes in beneficial ownership of securities107/01/2020
4Statement of changes in beneficial ownership of securities107/01/2020
4Statement of changes in beneficial ownership of securities107/01/2020
4Statement of changes in beneficial ownership of securities106/30/2020
4Statement of changes in beneficial ownership of securities107/01/2020
4Statement of changes in beneficial ownership of securities107/01/2020
4Statement of changes in beneficial ownership of securities107/01/2020
4Statement of changes in beneficial ownership of securities107/01/2020
4Statement of changes in beneficial ownership of securities107/01/2020
4Statement of changes in beneficial ownership of securities106/11/2020
4Statement of changes in beneficial ownership of securities106/02/2020
8-KCurrent report pursuant to Section 13 or 15(d)5106/02/2020
424B5Prospectus [Rule 424(b)(5)]7506/02/2020
424B5Prospectus [Rule 424(b)(5)]7506/01/2020
8-KCurrent report pursuant to Section 13 or 15(d)405/29/2020
<<
First
<
Prev
123456789101112131415